Novel Vaccines Improve Potential for European Vaccines Man...(Pharmaceuticals & Biotechnology Gro...),Health
Navigation Links
Novel Vaccines Improve Potential for European Vaccines Manufacturers
Date:1/14/2009
Pharmaceuticals & Biotechnology Growth Partnership Services Programme, which also includes research in the following markets: European Therapeutic Monoclonal Antibody Markets, European Human Growth Hormones Market, European Pharma/biotech Contract Manufacturing Markets: A Strategic Outlook and European Drug Delivery Markets - Opportunity Analysis. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://frost.com.
European Vaccines Market
M276
Contact:
Katja Feick
Corporate Communications
P: +49 (0) 69 77 0 33 43
E: katja.feick@frost.com
'/>"/>
| SOURCE Frost & Sullivan Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. University of Ottawa Heart Institute Scientists Successfully Develop Novel Biomaterial to Help Grow New Blood Vessels
2. Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
3. Frost & Sullivan Lauds Toscana Biomarkers Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases
4. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
5. Novel prostate cancer vaccine taking aim at cancer cell sweet spot
6. Onyx Pharmaceuticals Acquires Option to License Novel Highly Specific JAK2 Inhibitors From S*BIO
7. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
8. Mutations common to cancer and developmental disorder examined in a novel disease model
9. Labopharm to host webcast presentation on novel trazodone formulation - tomorrow (Dec.16/08) at 10:00 a.m. ET
10. Development of Novel Assays Vital for the European Immunoassay Diagnostics Market
11. FDA Grants NeoVistas Request to Utilize Novel Wet AMD Treatment in Compassionate Case
Post Your Comments:
Breaking Medicine News(10 mins):Health News:EAT CLEANER Brand Becomes a Trusted Partner of Healthy Child Healthy World Making Food Safer for Families 2Health News:EAT CLEANER Brand Becomes a Trusted Partner of Healthy Child Healthy World Making Food Safer for Families 3Health News:The New York Eye and Ear Infirmary Announces Partnership with ZocDoc 2Health News:Fastrack Announces Major Expansion 2Health News:Fastrack Announces Major Expansion 3Health News:Okuma Real Help Machine Tool Giveaway Finalists Announced 2Health News:Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine 2Health News:Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine 3
[0] EAT CLEANER Brand Becomes a Trusted Partner of Healthy Child Healthy World Making Food Safer for Families [0] The New York Eye and Ear Infirmary Announces Partnership with ZocDoc[0] Fastrack Announces Major Expansion[0] Okuma Real Help Machine Tool Giveaway Finalists Announced [0] Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine
Other Medicine News:Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 2Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 3Health News:StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los Angeles 4Health News:March of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a Crisis 2Health News:Differing attitudes found between women and doctors concerning menstrual suppression 2Health News:Mayors Express Frustration Over President Bush's Veto to SCHIP Legislation 2Health News:Los Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. Levenson 2Health News:APHA Deeply Troubled by Bush Veto of CHIP 2
StemCyte, Inc. Ranked Number Six in Deloitte's Technology Fast 50 Program for Los AngelesMarch of Dimes NICU Family Support(R) Programs Give Wisconsin Families Comfort and Information during a CrisisDiffering attitudes found between women and doctors concerning menstrual suppressionMayors Express Frustration Over President Bush's Veto to SCHIP LegislationLos Angeles Jewish Home Support Group Continues High-Profile Speaker Program With Noted Legal Scholar and Expert Laurie L. LevensonAPHA Deeply Troubled by Bush Veto of CHIP
Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 2Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 4Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Health Robotics Announces American Joint Venture With i v SOFT 52770 1Health Robotics Announces American Joint Venture With i v SOFT 52770 2Health Robotics Announces American Joint Venture With i v SOFT 52770 3Cardium Regains Listing Compliance with NYSE Amex 13207 1Cardium Regains Listing Compliance with NYSE Amex 13207 2Cardium Regains Listing Compliance with NYSE Amex 13207 3American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing 52765 1American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing 52765 2American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing 52765 3American CareSource Holdings Increases ACS Networks Convenience and Quality With MinuteClinic Signing 52765 4
Other Medicine Technology:ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR 2ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR 3Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 2Karmanos Physician-Scientists Examine Racial Disparities in,Patients with Gynecologic Cancer 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |